How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Cervical Cancer Trials

Select Clinical Trial

Protocol Number: Regeneron R2810-ONC-1676/GOG 3016 (CVP 1601) 

Protocol Title: An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Therapy of Investigator's Choice Chemotherapy in Recurrent or Metastatic Platinum-Refractory Cervical Carcinoma

Eligibility: Women, ages 18 or older, with progression or recurrence of cervical cancer

Contact Information: (910) 715-2200






Clara McLean House
Make a Donation
News & Events